A Mathematical Model of Cell Cycle Progression Applied to the MCF-7 Breast Cancer Cell Line

被引:0
|
作者
Kate Simms
Nigel Bean
Adrian Koerber
机构
[1] University of Adelaide,Applied Mathematics
来源
关键词
Cell cycle; Mathematical model;
D O I
暂无
中图分类号
学科分类号
摘要
In this paper, we present a model of cell cycle progression and apply it to cells of the MCF-7 breast cancer cell line. We consider cells existing in the three typical cell cycle phases determined using flow cytometry: the G1, S, and G2/M phases. We further break each phase up into model phases in order to capture certain features such as cells remaining in phases for a minimum amount of time. The model is also able to capture the environmentally responsive part of the G1 phase, allowing for quantification of the number of environmentally responsive cells at each point in time. The model parameters are carefully chosen using data from various sources in the biological literature. The model is then validated against a variety of experiments, and the excellent fit with experimental results allows for insight into the mechanisms that influence observed biological phenomena. In particular, the model is used to question the common assumption that a ‘slow cycling population’ is necessary to explain some results. Finally, an extension is proposed, where cell death is included in order to accurately model the effects of tamoxifen, a common first line anticancer drug in breast cancer patients. We conclude that the model has strong potential to be used as an aid in future experiments to gain further insight into cell cycle progression and cell death.
引用
收藏
页码:736 / 767
页数:31
相关论文
共 50 条
  • [41] Role of β-Estradiol in MCF-7 Breast Cancer Cell Line Based on the Bioinformatics Analysis
    Wang, Rong
    Li, Jinbin
    Yin, Chunyu
    Zhao, Di
    Zhao, Yulan
    Li, Yapeng
    Yin, Ling
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2019, 84 (03) : 268 - 276
  • [42] Apoptosis induced by diallyl disulfide in human breast cancer cell line MCF-7
    Lei, Xiao-yong
    Yao, Shu-qiong
    Zu, Xu-yu
    Huang, Ze-xiang
    Liu, Li-juan
    Zhong, Miao
    Zhu, Bing-yang
    Tang, Sheng-song
    Liao, Duan-fang
    ACTA PHARMACOLOGICA SINICA, 2008, 29 (10) : 1233 - 1239
  • [43] CARICA PAPAYA: ANTI-CANCER ACTIVITY IN MCF-7 BREAST CANCER CELL LINE
    Mahendran, V. S.
    Sophiya, K.
    Malavika, S. Sruthi
    Suganthi, B.
    Sujitha, E.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2021, 12 (01): : 176 - 182
  • [44] Avoiding the Interference of Doxorubicin with MTT Measurements on the MCF-7 Breast Cancer Cell Line
    Luis, Carla
    Castano-Guerrero, Yuselis
    Soares, Raquel
    Sales, Goreti
    Fernandes, Ruben
    METHODS AND PROTOCOLS, 2019, 2 (02) : 1 - 5
  • [45] Cationic vesicles for efficient shRNA transfection in the MCF-7 breast cancer cell line
    Mokhtary, Pardis
    Javan, Bita
    Sharbatkhari, Mahrokh
    Soltani, Alireza
    Erfani-Moghadam, Vahid
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 : 7107 - 7121
  • [46] Enhancement of radiosensitivity of the MCF-7 breast cancer cell line with human chorionic gonadotropin
    Pond-Tor, S
    Rhodes, RG
    Dahlberg, PE
    Leith, JT
    McMichael, J
    Dahlberg, AE
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 72 (01) : 45 - 51
  • [47] Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer
    Huang, Chao-You
    Han, Zheng
    Li, Xi
    Xie, Hui-Hua
    Zhu, Shan-Shan
    ONCOLOGY LETTERS, 2017, 14 (03) : 3623 - 3627
  • [48] INCORPORATION OF ALPHAFETOPROTEIN BY THE MCF-7 HUMAN-BREAST CANCER CELL-LINE
    URIEL, J
    FAILLYCREPIN, C
    VILLACAMPA, MJ
    PINEIRO, A
    GEUSKENS, M
    TUMOUR BIOLOGY, 1984, 5 (01): : 41 - 51
  • [49] Antiproliferative and antimigratory activities of bisphosphonates in human breast cancer cell line MCF-7
    Buranrat, Benjaporn
    Bootha, Supavadee
    ONCOLOGY LETTERS, 2019, 18 (02) : 1246 - 1258
  • [50] Effects of Docetaxel, Doxorubicin and Cyclophosphamide on Human Breast Cancer Cell Line MCF-7
    Trebunova, Marianna
    Laputkova, Galina
    Slaba, Eva
    Lacjakova, Kamila
    Verebova, Aneta
    ANTICANCER RESEARCH, 2012, 32 (07) : 2849 - 2854